Laekna Inc., a biopharmaceutical company listed on the Hong Kong Stock Exchange (stock code: 2105), has filed an updated list of directors and their roles. The Board is chaired by Dr. LU Chris Xiangyang, who also serves as Chief Executive Officer. Other executive directors include Ms. XIE Ling and Dr. GU Xiang-Ju Justin. The non-executive directors are Dr. WANG David Guowei and Mr. SUN Yuan. Independent non-executive directors comprise Dr. YIN Xudong, Dr. LI Min, and Mr. ZHOU Jian. Committee memberships are as follows: Dr. LU Chris Xiangyang chairs the Nomination and Corporate Governance Committee, with Ms. XIE Ling, Dr. LI Min, and Mr. ZHOU Jian as members. Mr. ZHOU Jian chairs the Audit Committee, joined by Dr. WANG David Guowei and Dr. LI Min as members. The Remuneration Committee is chaired by Dr. YIN Xudong, with Ms. XIE Ling and Mr. ZHOU Jian serving as members.